PERRIGO Co plc

Perrigo Company plc (NASDAQ: PRGO) is a leading pure-play self-care company with more than a century of history providing high-quality health and wellness solutions to consumers. The company operates through two primary reportable segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). CSCA comprises the company's consumer self-care business in the United States and Canada, while CSCI encompasses operations outside North America, primarily in Europe and Australia. The company's website is www.perrigo.com.

Perrigo develops, manufactures, and markets a diverse portfolio of over-the-counter self-care products across multiple categories including upper respiratory, nutrition, digestive health, pain and sleep aids, oral care, healthy lifestyle, skin care, women's health, and vitamins, minerals, and supplements. The company operates as both a leading store brand private label provider and owner of select branded products including Opill, Mederma, Compeed, ellaOne, Solpadeine, Jungle Formula, and NiQuitin. No single product represents more than five percent of total revenue, reflecting the company's diversified portfolio approach.

The company maintains a global operational footprint with approximately 8,100 full-time and part-time employees across 31 countries. Primary manufacturing facilities are located in the United States, with additional operations in the United Kingdom, Belgium, France, Germany, and China, supplemented by a joint venture in China. Perrigo also operates logistics facilities throughout the United States, Europe, and Australia.

Walmart Inc. represents the company's largest customer, accounting for approximately 12.9 percent of consolidated net sales, while the top ten customers collectively represent 47 percent of total sales. The company serves major global, national, and regional retail drug, supermarket, mass merchandise chains, e-commerce retailers, and wholesalers.

Perrigo's competitive advantages include a diverse product portfolio with leadership in first-to-market development, experienced research and development capabilities, deep consumer understanding, expansive global commercial infrastructure, supply chain breadth leveraging economies of scale, and quality cost-effectiveness throughout manufacturing and distribution networks. The company's strategic initiatives include the Supply Chain Reinvention Program and Project Energize, designed to reduce structural costs, improve profitability, and strengthen supply chain resilience.